Clinical Trial Update: Alzheimer's Disease Prevention Trial [Phase 3]

View source ↗

Summary

A Phase 3 Alzheimer's disease prevention trial conducted by the National Institute on Aging has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer Disease, Memory Disorders | Phase 3 | Status: COMPLETED